Tech Company Financing Transactions
Wandercraft Funding Round
On 6/11/2025, Wandercraft secured $75 million in Series D financing from Bpifrance, CEMAG Invest and European Investment Bank.
Transaction Overview
Company Name
Announced On
6/11/2025
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series D
Investors
Proceeds Purpose
The new funding will help propel Wandercraft into its next phase of growth: bringing Eve, the world's first self-balancing personal exoskeleton, to market as early as 2026, expanding clinical adoption of its flagship rehabilitation system, Atalante X, and developing and deploying Calvin-40, its humanoid robot, intended for physically demanding tasks.
Company Information
Company Status
Private & Independent
Industry
Robotics
Mailing Address
88 rue rivoli
Paris, 75004
France
Paris, 75004
France
Phone
Website
Email Address
Overview
Wandercraft 's job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. In our world premiere clinical trials, persons with paraplegia walked human-like, autonomously and without crutches. The Wanderteam walks on the edge of robotics. We cooperate with world class university labs and medical centers in Europe and the US.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthieu Masselin
Browse more venture capital transactions:
Prev: 6/11/2025: Tracksuit venture capital transaction
Next: 6/11/2025: Fermat venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs